Cetnosurge 0.25mg Injection
By Cetnosurge
Rx
1 Injection in a Vial

Composition
Cetrorelix(0.25mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
July, 2025

liver
When using Cetnosurge 0.25mg Injection, it's essential to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. It is important to consult your doctor before starting treatment to ensure the appropriate dosage and monitor any potential effects on the liver.

kidney
Cetnosurge 0.25mg Injection should be used carefully in individuals with kidney problems. Adjusting the dosage may be necessary, so consulting your doctor is essential. Avoid using this injection if you have severe kidney disease.

alcohol
When taking Cetnosurge 0.25mg Injection, it is advisable to use caution when drinking alcohol. Please consult your doctor before consuming alcohol while using this medication.

driving
Cetnosurge 0.25mg Injection typically does not impact driving ability.

pregnancy
Cetnosurge 0.25mg Injection should be avoided during pregnancy due to potential harm to the baby, as studies on pregnant women and animals have shown significant negative effects. It is best to consult your doctor for guidance.

breastfeeding
Cetnosurge 0.25mg Injection is not recommended while breastfeeding as it may harm the baby due to potential toxicity.
Habit Forming | No |
Chemical Class | Polypeptides |
Therapeutic Class | - |
Action Class | GNRH antagonists |
₹1500
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024